These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7439612)

  • 21. [In practice: use of vitamin K antagonists].
    Heidinger K
    Pharm Unserer Zeit; 2004; 33(3):236-43. PubMed ID: 15208912
    [No Abstract]   [Full Text] [Related]  

  • 22. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update.
    Vandermeulen E; Singelyn F; Vercauteren M; Brichant JF; Ickx BE; Gautier P; ;
    Acta Anaesthesiol Belg; 2005; 56(2):139-46. PubMed ID: 16013658
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of blunt duodenal injuries.
    Sriussadaporn S; Pak-art R; Sriussadaporn S; Kritayakirana K
    J Med Assoc Thai; 2004 Nov; 87(11):1336-42. PubMed ID: 15825710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relation of pelentan to vitamin K].
    LIBANSKY J; DIENSTBIER Z; POLAK B
    Cas Lek Cesk; 1953 Oct; 92(40):1094-6. PubMed ID: 13116139
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review.
    Ford SK; Moll S
    Curr Opin Hematol; 2008 Sep; 15(5):504-8. PubMed ID: 18695375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitamin K and osteoporosis].
    Luo LZ; Xu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):346-9. PubMed ID: 12905754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up after endoscopic forceps biopsies for early stage duodenal carcinoid: case report and review of endoscopic treatments.
    Urso E; Pucciarelli S; Cassaro M; Agostini M; Nitti D
    Endoscopy; 2007 Feb; 39 Suppl 1():E128. PubMed ID: 17440849
    [No Abstract]   [Full Text] [Related]  

  • 28. [Post-traumatic hematoma of the duodenum].
    Hoeffel JC; Galloy MA; Gaconnet E; Arnould V; Claudon M
    J Radiol; 1998 Sep; 79(9):897-8. PubMed ID: 9791774
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vitamin K antagonists and their successors. The Danish Society for Thrombosis and Hemostasis].
    Nielsen JD;
    Ugeskr Laeger; 2007 Mar; 169(12):1134. PubMed ID: 17394845
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombophlebitis--use of vitamin K antagonists].
    Schwieder G
    Internist (Berl); 1997 Mar; 38(3):261. PubMed ID: 9173050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between amiodarone and vitamin K antagonists.
    Prescrire Int; 2003 Apr; 12(64):64. PubMed ID: 12674126
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of vitamin K antagonists on the synthesis of vitamins by Lactobacillus arabinosus].
    CIMINO G
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):664-7. PubMed ID: 13105996
    [No Abstract]   [Full Text] [Related]  

  • 34. Exposure to vitamin K antagonists during pregnancy.
    Schaefer C
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):509-10. PubMed ID: 17147236
    [No Abstract]   [Full Text] [Related]  

  • 35. A rebuttal: vitamin K antagonists and cancer survival.
    Zacharski LR; Henderson WG
    Thromb Haemost; 2002 Jul; 88(1):173-4; author reply 175. PubMed ID: 12152670
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrent thromboembolism after treatment with vitamin K antagonists.
    van Dongen CJ; Vink R; Hutten BA; Buller HR; Prins MH
    Arch Intern Med; 2003 Dec 8-22; 163(22):2793. PubMed ID: 14662641
    [No Abstract]   [Full Text] [Related]  

  • 37. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
    Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations on bleeding and nonbleeding complications of vitamin K antagonists.
    Ansell J
    Clin Adv Hematol Oncol; 2007 Jul; 5(7):517-8, 554. PubMed ID: 17679924
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.
    Neal M; Crowther M; Douketis J; Verhovsek M; Stidley C; Garcia D
    Thromb Res; 2008; 122(6):864-6. PubMed ID: 18678398
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.
    Ageno W; Garcia D; Aguilar MI; Douketis J; Finazzi G; Imberti D; Iorio A; Key NS; Lim W; Marietta M; Prisco D; Sarode R; Testa S; Tosetto A; Crowther M
    Am J Hematol; 2009 Sep; 84(9):584-8. PubMed ID: 19610020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.